CTRI/2020/04/024674尚未招募未知
An open labelled randomised controlled parallel group clinical study to evaluate the efficacy Of PRASARINI SANDHANAM in management of AMAVATA W.S.R TO RHEUMATOID ARTHRITIS
Dr Ramyashree Nagendra0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Willing to give informed consent for research
- •2. Subjects who satisfy 4 criteria out of 7 of ARA
- •3. Subjects with classical signs and symptoms of Amavata
排除标准
- •1. Subjects suffering from Rheumatoid arthritis secondary to any systemic diseases
- •2. Patients on any other medications like DMARD, NSAID, Corticosteroids
- •3. Patients having complications like swan neck deformity, ulnar deviation and any other diseases which interfere with the course of disease and treatment will be excluded
研究者
相似试验
尚未招募
不适用
Can we delay the near vision defect by AyurvedaCTRI/2022/05/042712Dr Srishti Vyas
已完成
不适用
An open-label, randomized, controlled, parallel-group comparative study on the effectiveness of 111-lunchbox dietary method as a dietary management in type 2 diabetic patientsJPRN-UMIN000003494111-lunchbox Study Group60
进行中（未招募）
1 期
A trial to compare the efficacy and safety of individualised FE 999049 (follitropin delta) dosing in women undergoing controlled ovarian stimulatioInfertility in women undergoing assisted reproductive technologies (ART) such as an in vitro fertilisation (IVF) or intracytoplasmic sperm injection (ICSI) cycleMedDRA version: 20.1Level: LLTClassification code 10016398Term: Female infertilitySystem Organ Class: 100000004872MedDRA version: 21.0Level: LLTClassification code 10016403Term: Female infertility of tubal originSystem Organ Class: 100000004872MedDRA version: 21.1Level: LLTClassification code 10025511Term: Male infertility, unspecifiedSystem Organ Class: 100000004872MedDRA version: 21.0Level: LLTClassification code 10014787Term: Endometriosis of uterusSystem Organ Class: 100000004872MedDRA version: 21.0Level: LLTClassification code 10014784Term: Endometriosis of ovarySystem Organ Class: 100000004872EUCTR2017-002783-40-DKFerring Pharmaceuticals A/S400
进行中（未招募）
1 期
A trial to compare the efficacy and safety of individualised FE 999049 (follitropin delta) dosing in women undergoing controlled ovarian stimulatioInfertility in women undergoing assisted reproductive technologies (ART) such as an in vitro fertilisation (IVF) or intracytoplasmic sperm injection (ICSI) cycleMedDRA version: 20.1 Level: LLT Classification code 10016398 Term: Female infertility System Organ Class: 100000004872MedDRA version: 20.0 Level: LLT Classification code 10016403 Term: Female infertility of tubal origin System Organ Class: 100000004872MedDRA version: 20.0 Level: LLT Classification code 10025511 Term: Male infertility, unspecified System Organ Class: 100000004872MedDRA version: 20.0 Level: LLT Classification code 10014787 Term: Endometriosis of uterus System Organ Class: 100000004872MedDRA version: 20.0 Level: LLT Classification code 10014784 Term: Endometriosis of ovary System Organ Class: 100000004872EUCTR2017-002783-40-NLFerring Pharmaceuticals A/S400
进行中（未招募）
1 期
A trial to compare the efficacy and safety of individualised FE 999049 (follitropin delta) dosing in women undergoing controlled ovarian stimulatioInfertility in women undergoing assisted reproductive technologies (ART) such as an in vitro fertilisation (IVF) or intracytoplasmic sperm injection (ICSI) cycleMedDRA version: 20.1Level: LLTClassification code 10016398Term: Female infertilitySystem Organ Class: 100000004872MedDRA version: 20.0Level: LLTClassification code 10016403Term: Female infertility of tubal originSystem Organ Class: 100000004872MedDRA version: 20.0Level: LLTClassification code 10025511Term: Male infertility, unspecifiedSystem Organ Class: 100000004872MedDRA version: 20.0Level: LLTClassification code 10014787Term: Endometriosis of uterusSystem Organ Class: 100000004872MedDRA version: 20.0Level: LLTClassification code 10014784Term: Endometriosis of ovarySystem Organ Class: 100000004872EUCTR2017-002783-40-NOFerring Pharmaceuticals A/S400